Cargando…
Strategic planning to augment the testing capacity for COVID-19 in India
BACKGROUND & OBJECTIVES: Nearly 5,500 tests for coronavirus disease 2019 (COVID-19) had been conducted on March 31, 2020 across the Indian Council of Medical Research (ICMR)-approved public and private laboratories in India. Given the need to rapidly increase testing coverage, we undertook an ex...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366548/ https://www.ncbi.nlm.nih.gov/pubmed/32362646 http://dx.doi.org/10.4103/ijmr.IJMR_1166_20 |
_version_ | 1783560241348083712 |
---|---|
author | Gupta, Nivedita Bhatnagar, Tarun Rade, Kiran Murhekar, Manoj Gangakhedkar, Raman R. Nagar, Anu |
author_facet | Gupta, Nivedita Bhatnagar, Tarun Rade, Kiran Murhekar, Manoj Gangakhedkar, Raman R. Nagar, Anu |
author_sort | Gupta, Nivedita |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Nearly 5,500 tests for coronavirus disease 2019 (COVID-19) had been conducted on March 31, 2020 across the Indian Council of Medical Research (ICMR)-approved public and private laboratories in India. Given the need to rapidly increase testing coverage, we undertook an exercise to explore and quantify interventions to increase the daily real-time reverse transcription-polymerase chain reaction (qRT-PCR)-based testing capacity over the next few months. The objective of this exercise was to prepare a potential plan to scale-up COVID-19 testing in India in the public sector. METHODS: Potential increase in daily testing capacity of the existing public laboratories was calculated across the three base scenarios of shifts (9, 16 and 24 h). Additional testing capacity was added for each shift scenario based on interventions ranging from procurement of additional qRT-PCR machines, leveraging spare capacity on available qRT-PCR machines not drafted into COVID-19 testing, to in-laboratory process optimization efforts. RESULTS: Moving to a 24 h working model in the existing approved laboratories can enhance the daily testing capacity to 40,464 tests/day. The capacity can be further bolstered by leveraging qRT-PCR and nucleic acid amplification test (NAAT)-based machines available with the Multidisciplinary Research Units (MRUs), National AIDS Control Organisation (NACO) and National Tuberculosis Elimination Programme (NTEP). Using combination/multiplex kits, and provision of automated RNA extraction platforms at all laboratories could also optimize run time and contribute to capacity increase by 1.5-2 times. INTERPRETATION & CONCLUSIONS: Adopting these interventions could help increase public sector's daily testing capacity to nearly 100,000-120,000 tests/day. It is important to note that utilization of the scaled-up testing capacity will require deployment of additional workforce, procurement of corresponding commodities for testing and scale-up of sample collection and transportation efforts. |
format | Online Article Text |
id | pubmed-7366548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-73665482020-07-21 Strategic planning to augment the testing capacity for COVID-19 in India Gupta, Nivedita Bhatnagar, Tarun Rade, Kiran Murhekar, Manoj Gangakhedkar, Raman R. Nagar, Anu Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Nearly 5,500 tests for coronavirus disease 2019 (COVID-19) had been conducted on March 31, 2020 across the Indian Council of Medical Research (ICMR)-approved public and private laboratories in India. Given the need to rapidly increase testing coverage, we undertook an exercise to explore and quantify interventions to increase the daily real-time reverse transcription-polymerase chain reaction (qRT-PCR)-based testing capacity over the next few months. The objective of this exercise was to prepare a potential plan to scale-up COVID-19 testing in India in the public sector. METHODS: Potential increase in daily testing capacity of the existing public laboratories was calculated across the three base scenarios of shifts (9, 16 and 24 h). Additional testing capacity was added for each shift scenario based on interventions ranging from procurement of additional qRT-PCR machines, leveraging spare capacity on available qRT-PCR machines not drafted into COVID-19 testing, to in-laboratory process optimization efforts. RESULTS: Moving to a 24 h working model in the existing approved laboratories can enhance the daily testing capacity to 40,464 tests/day. The capacity can be further bolstered by leveraging qRT-PCR and nucleic acid amplification test (NAAT)-based machines available with the Multidisciplinary Research Units (MRUs), National AIDS Control Organisation (NACO) and National Tuberculosis Elimination Programme (NTEP). Using combination/multiplex kits, and provision of automated RNA extraction platforms at all laboratories could also optimize run time and contribute to capacity increase by 1.5-2 times. INTERPRETATION & CONCLUSIONS: Adopting these interventions could help increase public sector's daily testing capacity to nearly 100,000-120,000 tests/day. It is important to note that utilization of the scaled-up testing capacity will require deployment of additional workforce, procurement of corresponding commodities for testing and scale-up of sample collection and transportation efforts. Wolters Kluwer - Medknow 2020 /pmc/articles/PMC7366548/ /pubmed/32362646 http://dx.doi.org/10.4103/ijmr.IJMR_1166_20 Text en Copyright: © 2020 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Gupta, Nivedita Bhatnagar, Tarun Rade, Kiran Murhekar, Manoj Gangakhedkar, Raman R. Nagar, Anu Strategic planning to augment the testing capacity for COVID-19 in India |
title | Strategic planning to augment the testing capacity for COVID-19 in India |
title_full | Strategic planning to augment the testing capacity for COVID-19 in India |
title_fullStr | Strategic planning to augment the testing capacity for COVID-19 in India |
title_full_unstemmed | Strategic planning to augment the testing capacity for COVID-19 in India |
title_short | Strategic planning to augment the testing capacity for COVID-19 in India |
title_sort | strategic planning to augment the testing capacity for covid-19 in india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366548/ https://www.ncbi.nlm.nih.gov/pubmed/32362646 http://dx.doi.org/10.4103/ijmr.IJMR_1166_20 |
work_keys_str_mv | AT guptanivedita strategicplanningtoaugmentthetestingcapacityforcovid19inindia AT bhatnagartarun strategicplanningtoaugmentthetestingcapacityforcovid19inindia AT radekiran strategicplanningtoaugmentthetestingcapacityforcovid19inindia AT murhekarmanoj strategicplanningtoaugmentthetestingcapacityforcovid19inindia AT gangakhedkarramanr strategicplanningtoaugmentthetestingcapacityforcovid19inindia AT nagaranu strategicplanningtoaugmentthetestingcapacityforcovid19inindia AT strategicplanningtoaugmentthetestingcapacityforcovid19inindia |